Cendakimab Shows Promise in Eosinophilic Esophagitis ...Middle East

Medscape - News
Interim phase 3 results showed the IL-13 monoclonal antibody improves histology and symptoms in EoE, even in participants with inadequate response or intolerance to steroids. Medscape Medical News

Hence then, the article about cendakimab shows promise in eosinophilic esophagitis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cendakimab Shows Promise in Eosinophilic Esophagitis )

Apple Storegoogle play

Last updated :

Also on site :